Scientech Research »

Allogene Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2025-09-30 $33k 27k 1.24

More positions owned by Scientech Research

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Applovin Corp Com Cl A (APP)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Alnylam Pharmaceuticals (ALNY)
Tilray (TLRY)
Uniqure Nv SHS (QURE)
Mongodb Cl A (MDB)
Insulet Corporation (PODD)
Transocean Registered Shs (RIG)
Zebra Technologies Corporati Cl A (ZBRA)
Robinhood Mkts Com Cl A (HOOD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Adobe Systems Incorporated (ADBE)

View all positions for Scientech Research

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics